|1.||Yokoyama, Shigeo: 1 article (01/2014)|
|2.||Hashimoto, Hisashi: 1 article (01/2014)|
|3.||Kashima, Kenji: 1 article (01/2014)|
|4.||Nishida, Haruto: 1 article (01/2014)|
|5.||Arakane, Motoki: 1 article (01/2014)|
|6.||Yada, Naomi: 1 article (01/2014)|
|7.||Daa, Tsutomu: 1 article (01/2014)|
|1.||Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/01/2014 - "In this study, 2 commercially available clones of TTF-1 monoclonal antibody, 8G7G3/1 and SPT24, were used for staining 38 cases of pulmonary squamous cell carcinoma, in combination with the CSA-II and the conventional detection system, EnVision. "
01/01/2014 - "We conclude that the use of the SPT24 monoclonal antibody with the CSA-II system can detect even weak expression of TTF-1 in pulmonary squamous cell carcinoma. "
01/01/2014 - "We hypothesized that the highly sensitive detection system, CSA-II, can visualize even faint expression of TTF-1 in pulmonary squamous cell carcinoma. "
01/01/2014 - "Significant expression of thyroid transcription factor-1 in pulmonary squamous cell carcinoma detected by SPT24 monoclonal antibody and CSA-II system."
|2.||Atrophic Muscular Disorders
12/01/1997 - "We have found that the cps1-12 mutation also confers (i) hypersensitivity to the immunosuppressant cyclosporin A (CsA), (ii) hypersensitivity to the drug papulacandin B, which specifically inhibits 1,3-beta-D-glucan synthesis both in vivo and in vitro, and (iii) thermosensitive growth at 37 degrees C. "